CANNABIXIR Trademark

Trademark Overview


On Thursday, June 14, 2018, a trademark application was filed for CANNABIXIR with the United States Patent and Trademark Office. The USPTO has given the CANNABIXIR trademark a serial number of 79243566. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Oxygen Handel GmbH. The CANNABIXIR trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:

Bleaching preparations for laundry use; non-medicated soaps; essential oils; non-medicated cosmetics; non-medicated hair lotions; non-medicated dentifrices; non-medicated toiletry preparations; non-medicated make-up; non-medicated soaps and gels; non-medicated bath preparations; non-medicated deodorants and antiperspirants; non-medicated skin, eye and nail care preparations; non-medicated hair preparations and treatments; essential oils and aromatic extracts; household cleaning preparations; air fragrancing preparations; household fragrances; balms, other than for medical purposes for use on hair, skin, lips; cosmetics and cosmetic preparations; oils for cosmetic purposes; massage oils; mineral oils for cosmetic purposes; ointments for cosmetic use; non-medicated body mist; cosmetic shower preparations; cosmetic, namely, fluid creams; body and facial butters; body and facial oils; facial peel preparations for cosmetic use; cleaning masks for the face; hair and body wash; cosmetic prepa...

Pharmaceuticals preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medical preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's diseas...

General Information


Serial Number79243566
Word MarkCANNABIXIR
Filing DateThursday, June 14, 2018
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6044448
Registration DateTuesday, May 5, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements


Goods and ServicesBleaching preparations for laundry use; non-medicated soaps; essential oils; non-medicated cosmetics; non-medicated hair lotions; non-medicated dentifrices; non-medicated toiletry preparations; non-medicated make-up; non-medicated soaps and gels; non-medicated bath preparations; non-medicated deodorants and antiperspirants; non-medicated skin, eye and nail care preparations; non-medicated hair preparations and treatments; essential oils and aromatic extracts; household cleaning preparations; air fragrancing preparations; household fragrances; balms, other than for medical purposes for use on hair, skin, lips; cosmetics and cosmetic preparations; oils for cosmetic purposes; massage oils; mineral oils for cosmetic purposes; ointments for cosmetic use; non-medicated body mist; cosmetic shower preparations; cosmetic, namely, fluid creams; body and facial butters; body and facial oils; facial peel preparations for cosmetic use; cleaning masks for the face; hair and body wash; cosmetic preparations for bath and shower; cosmetic creams and lotions; topical herbal extracts for cosmetic purposes; make-up preparations; beauty balm creams; beauty milk; beauty care cosmetics; cosmetics in the form of creams; beauty serums; none of the aforementioned goods containing cannabinoids
Goods and ServicesPharmaceuticals preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medical preparations for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; veterinary preparations for rodents, cats, dogs, guinea pigs, rabbits, for treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, diseases of the nerves, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, neuromuscular diseases, degenerative diseases, including glaucoma, cancer as well as side effects, including nausea, vomiting, lack of appetite and weight loss; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; dietary supplements for humans and animals; cachets for pharmaceutical purposes; medicated dentifrices; disinfectants and antiseptics; air deodorizers and air purifying preparations; medicated and sanitizing soaps and detergents for personal use; diagnostic preparations for medical use and veterinary use; natural remedies for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medical plasters; analgesics; appetite stimulant preparations; medicines for human purposes used for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; autonomic drugs for medical purposes; pharmaceutical preparations acting on the central nervous system; balms for medical purposes; balms for pharmaceutical purposes; sedatives; deodorants, other than for human beings or for animals; deodorizing room sprays; dragees for medicinal purposes; drugs for medical purposes; pharmaceutical preparations, namely, elixirs for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; anti-inflammatories; preparations for making medicated beverages; extracts of medicinal plants; ground hempseed fiber for use as a dietary supplement; medicated moisturizing body lotion; medicated moisturizing creams; liquid herbal supplements; nutraceuticals for use as a dietary supplement; topical gels for medical and therapeutic use, namely, pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; medicinal drinks; skin care preparations for medical use; medicinal herbs in dried or preserved form; extracts of medicinal herbs; homeopathic pharmaceuticals for use in treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; inhalants for medicinal purposes; capsules for medicines; chewing gum for medical purposes; germicides; medicinal herbs; smoking herbs for medical purposes; herbal extracts for medical purposes; herbal extracts for medicinal purposes; herbal beverages for medicinal use; herbal preparations for medical use; herbal teas for medicinal purposes; hempseed for pharmaceutical purposes; hempseed meal for pharmaceutical purposes; liniments; air deodorizing preparations; hemp milk for pharmaceutical purposes; hemp oil for pharmaceutical purposes; medicated shampoos; medicinal sprays; medicinal tea; medicated food supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; hempseed dietary supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; hempseed oil dietary supplements for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; prescription synthetic narcotics; nervines; nutraceutical preparations for therapeutic or medical purposes; medicinal oils; plant and herb extracts for medicinal use; pharmaceutical compositions for pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; reagents for medical use; syrups for pharmaceutical purposes; all of the aforementioned goods in particular for the treatment of pain, including chronic pain, neuropathic pain and fibromyalgia, mental diseases, including anxiety disorders, diseases of the nerves, depression, attention deficit/hyperactivity disorder, bipolar disorder and post-traumatic stress disorder, diseases of the central nervous system, including multiple sclerosis, spinal cord injury, epilepsy, Alzheimer's disease and autism, neuromuscular diseases, degenerative diseases, including glaucoma, cancer and insomnia as well as side effects, including nausea, vomiting, lack of appetite and weight loss; none of the aforementioned goods containing cannabinoids
Pseudo MarkCANNABIS ELIXIR

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 23, 2018
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxygen Handel GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameOxygen Handel GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameOxygen Handel GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events


Event DateEvent Description
Friday, December 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 11, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 11, 2020FINAL DISPOSITION PROCESSED
Wednesday, August 5, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Friday, April 3, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 18, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 18, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Friday, February 14, 2020NOTIFICATION PROCESSED BY IB
Wednesday, January 29, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 29, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 16, 2020ASSIGNED TO LIE
Tuesday, January 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 27, 2019REFUSAL PROCESSED BY IB
Thursday, June 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 20, 2019NON-FINAL ACTION E-MAILED
Thursday, June 20, 2019NON-FINAL ACTION WRITTEN
Wednesday, May 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 8, 2018REFUSAL PROCESSED BY IB
Saturday, November 17, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 16, 2018REFUSAL PROCESSED BY MPU
Thursday, November 15, 2018ASSIGNED TO EXAMINER
Saturday, October 27, 2018APPLICATION FILING RECEIPT MAILED
Friday, October 26, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 25, 2018NON-FINAL ACTION WRITTEN
Tuesday, October 23, 2018ASSIGNED TO EXAMINER
Tuesday, October 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 18, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB